Literature DB >> 8972541

Subjective and cardiovascular effects of intravenous nicotine in smokers and non-smokers.

R Soria1, J M Stapleton, S F Gilson, A Sampson-Cone, J E Henningfield, E D London.   

Abstract

The present study assessed the subjective and cardiovascular effects of intravenous nicotine in smokers and nonsmokers. Nonsmokers (n = 5) and smokers (n = 5) were administered a single dose of nicotine (0.75 or 1.5 mg) or saline on each of 3 days. The nicotine doses were given in ascending order in a double-blind fashion. Although smokers and nonsmokers manifested significant increases in systolic and diastolic blood pressure and heart rate 1 min after administration of all active test doses, the difference between peak heart rate and that measured at later times was greater in nonsmokers than in smokers. Nonsmokers and smokers also differed in subjective self-reports. In response to items on visual analogue scales indicative of positive effects (e.g., "good effects," "like drug," "use again," and "feel energetic"), smokers but not nonsmokers reported high scores (> 40) after nicotine injection. In addition, responses on the MBG and LSD subscales of the Addiction Research Center Inventory indicated that smokers experienced positive subjective effects after the test doses, whereas nonsmokers experienced disorientation. The fact that intravenous nicotine was not associated with positive subjective effects in nonsmokers indicates that repeated exposure is required to establish positive reinforcing effects of nicotine.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8972541     DOI: 10.1007/s002130050129

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  20 in total

1.  Euphoriant effects of nicotine in smokers: fact or artifact?

Authors:  Reuven Dar; Rachel Kaplan; Lior Shaham; Hanan Frenk
Journal:  Psychopharmacology (Berl)       Date:  2007-01-19       Impact factor: 4.530

2.  Nicotine as a typical drug of abuse in experimental animals and humans.

Authors:  Bernard Le Foll; Steven R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  2005-10-05       Impact factor: 4.530

3.  Effects of intravenous nicotine on prepulse inhibition in smokers and non-smokers: relationship with familial smoking.

Authors:  David J Drobes; David A MacQueen; Melissa D Blank; Michael E Saladin; Robert J Malcolm
Journal:  Psychopharmacology (Berl)       Date:  2013-04-28       Impact factor: 4.530

4.  Effects of pregabalin on smoking behavior, withdrawal symptoms, and cognitive performance in smokers.

Authors:  Aryeh I Herman; Andrew J Waters; Sherry A McKee; Mehmet Sofuoglu
Journal:  Psychopharmacology (Berl)       Date:  2011-09-24       Impact factor: 4.530

5.  Studying the interactive effects of menthol and nicotine among youth: An examination using e-cigarettes.

Authors:  Suchitra Krishnan-Sarin; Barry G Green; Grace Kong; Dana A Cavallo; Peter Jatlow; Ralitza Gueorguieva; Eugenia Buta; Stephanie S O'Malley
Journal:  Drug Alcohol Depend       Date:  2017-08-31       Impact factor: 4.492

Review 6.  Human nicotine conditioning requires explicit contingency knowledge: is addictive behaviour cognitively mediated?

Authors:  Lee Hogarth; Theodora Duka
Journal:  Psychopharmacology (Berl)       Date:  2005-09-21       Impact factor: 4.530

Review 7.  Hormones, nicotine, and cocaine: clinical studies.

Authors:  Nancy K Mello
Journal:  Horm Behav       Date:  2009-10-14       Impact factor: 3.587

Review 8.  Effects of nicotine in experimental animals and humans: an update on addictive properties.

Authors:  Bernard Le Foll; Steven R Goldberg
Journal:  Handb Exp Pharmacol       Date:  2009

Review 9.  Do smokers self-administer pure nicotine? A review of the evidence.

Authors:  Reuven Dar; Hanan Frenk
Journal:  Psychopharmacology (Berl)       Date:  2004-03-05       Impact factor: 4.530

10.  Patterns of nicotinic receptor antagonism II: cardiovascular effects in rats.

Authors:  Emily M Jutkiewicz; Kenner C Rice; F Ivy Carroll; James H Woods
Journal:  Drug Alcohol Depend       Date:  2013-01-18       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.